Page last updated: 2024-08-23

epirubicin and Neuralgia

epirubicin has been researched along with Neuralgia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Matta, C; Mensah-Nyagan, AG; Meyer, L; Taleb, O1
Andersen, KG; Eckhoff, L; Gärtner, R; Jensen, MB; Kehlet, H; Kroman, N1

Other Studies

2 other study(ies) available for epirubicin and Neuralgia

ArticleYear
Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy-Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment.
    Neurotoxicity research, 2020, Volume: 38, Issue:1

    Topics: Analgesics; Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Duloxetine Hydrochloride; Epirubicin; Female; Neoadjuvant Therapy; Neuralgia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pregnanolone; Sciatic Nerve

2020
Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide.
    Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Sectional Studies; Cyclophosphamide; Denmark; Docetaxel; Epirubicin; Female; Fluorouracil; Foot; Hand; Humans; Lymph Node Excision; Mastectomy; Middle Aged; Multivariate Analysis; Neuralgia; Pain Measurement; Prevalence; Prospective Studies; Radiotherapy; Risk Factors; Sensation Disorders; Severity of Illness Index; Surveys and Questionnaires; Taxoids

2012